Effect of subchronic treatment with metrifonate and tacrine on brain cholinergic function in aged F344 rats

European Journal of Pharmacology

Volumn 354, Issue 1, 1998, Pages 17-24

  Giovannini, Maria Grazia ^a   Scali, Carla ^a   Bartolini, Luciano ^a   Schmidt, Bernard ^b   Pepeu, Giancarlo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CNS Research   (Germany)

Author keywords

Acetylcholine release; Aging; Alzheimer's disease; Cholinesterase inhibitor; Microdialysis

Indexed keywords

CHOLINE ACETYLTRANSFERASE; CHOLINESTERASE INHIBITOR; METRIFONATE; TACRINE;

ACETYLCHOLINE RELEASE; AGED; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CHOLINERGIC SYSTEM; CHOLINESTERASE INHIBITION; CONTROLLED STUDY; HIPPOCAMPUS; MALE; MICRODIALYSIS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ACETYLCHOLINE; ADMINISTRATION, ORAL; AGING; ANIMALS; BLOOD PRESSURE; BODY WEIGHT; CEREBRAL CORTEX; CHOLINE O-ACETYLTRANSFERASE; CHOLINERGIC FIBERS; CHOLINESTERASE INHIBITORS; DRUG ADMINISTRATION SCHEDULE; HEART RATE; HIPPOCAMPUS; MALE; RATS; RATS, INBRED F344; TACRINE; TRICHLORFON;

EID: 0031710171     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00429-4     Document Type: Article

References (58)

1. Aaltonen, M., Riekkinen, P., Sirviö, J., Riekkinen, P.J., 1991. Effects of THA on passive avoidance and spatial performance in quisqualic acid nucleus basalis-lesioned rats. Pharmacol. Biochem. Behav. 39, 563-567.
2. Bartus, R.T., Dean, R.L., Beer, B., Lippa, A.S., 1982. The cholinergic hypothesis of geriatric memory dysfunction. Science 217, 408-417.
3. Bassant, M.H., Jazat-Poindessous, F., Lamour, Y., 1996. Effect of metri3 fonate, a cholinesterase inhibitor, on local cerebral glucose utilization in young and aged rats. J. Cereb. Blood Flow Metab. 16, 1014-1025.
4. Becker, R.E., Giacobini, E., 1988. Mechanisms of cholinesterase inhibition in senile dementia of Alzheimer type: clinical, pharmacological and therapeutic aspects. Drug Dev. Res. 12, 163-195.
5. Becker, R.E., Colliver, J., Elble, R., Feldman, E., Giacobini, E., Kumar, V., Markwell, S., Moriearty, P., Parks, R., Shillcutt, S.D., Unni, L., Vicari, S., Womack, C., Zee, R.F., 1990. Effects of metrifonate, a long-acting cholinesterase inhibitor, in Alzheimer's disease. Drug Dev. Res. 19, 425-434.
6. Blokland, A., Hinz, V., Schmidt, B.H., 1995. Effects of metrifonate and tacrine in the spatial Morris task and modified Irwin test: evaluation of the efficacy/safety profile in rats. Drug Dev. Res. 36, 166-179.
7. Bowen, D.M., Francis, P.T., Pangalos, M.N., Stephens, P.M., Procter, A.W., Chessell, I.P., 1992. 'Traditional' pharmacotherapy may succeed in Alzheimer therapy. Trends Neurosci. 15, 84-85.
8. Bowen, D.M., Francis, P.T., Chessell, I.P., Webster, M.T., 1994. Neuro-transmission - the link integrating Alzheimer research?. TiNS 17, 149-150.
9. Bryson, H.M., Benfield, P., 1997. Donepezil. Drugs and Aging 10, 234-239.
10. Buyukuysal, R.L., Wurtman, R.J., 1989. Tetrahydroaminoacridine but not 4-aminopyridine inhibits high-affinity choline uptake in striatal and hippocampal synaptosomes. Brain Res. 482, 371-375.
11. Cimini, C.M., Zambraski, E.J., 1985. Non-invasive blood pressure measurement in yucatan miniature swine using tail-cuff sphygmomanometry. Lab. Anim. Sci. 35, 412-417.
12. Collerton, D., 1986. Cholinergic function and intellectual decline in Alzheimer's disease. Neuroscience 19, 1-28.
13. Cuadra, G., Summers, K., Giacobini, E., 1994. Cholinesterase inhibitor effects on neurotransmitters in rat cortex in vivo. J. Pharmacol. Exp. Ther. 270, 277-284.
14. Cummings, J.L., Bieber, F., Mas, J., Orazem, J., Gulanski, B., 1996. Metrifonate in Alzheimer's disease - results of a dose-finding study. J. Neurobiol. 17 (4S), S153-S154.
15. Cummings, J.L., Cyrus, P.A., Bieber, F., Mas, J., Orazem, J., Gulanski, B., The Metrifonate Study Group, 1998. Metrifonate treatment of the cognitive deficits of Alzheimer's disease. Neurology, in press.
16. Damsma, G., Lammerts van Bueren, D., Westerink, B.H.C., Horn, A.S., 1987. Determination of acetylcholine in the femtomole range by means of HPLC, a post-column enzyme reactor, and electro-chemical detection. Chromatographia 24, 827-831.
17. Davis, K.L., Powchik, P., 1995. Tacrine. Lancet 345, 625.
18. DeSarno, P., Pomponi, M., Giacobini, E., Tang, X., Williams, E., 1989. The effect of heptylphysostigmine, a new cholinesterase inhibitor, on the central cholinergic system of the rat. Neurochem. Res. 14, 971-977.
19. Everitt, B.J., Robbins, T.W., 1997. Central cholinergic system and cognition. Annu. Rev. Psychol. 48, 649-684.
20. Fischer, W., Wictorin, K., Bjorklund, A., Williams, L.R., Varon, S., Gage, F.H., 1987. Amelioration of cholinergic neurons atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature 329, 65-68.
21. Fonnum, F., 1975. A rapid radiochemical method for the determination of choline acetyltransferase. J. Neurochem. 24, 407-409.
22. Giacobini, E., 1991. The second generation of cholinesterase inhibitors: pharmacological aspects. In: Becker, R., Giacobini, E. (Eds.), Cholinergic Basis for Alzheimer Therapy. Birkhäuser, New York, pp. 247-262.
23. Giacobini, E., 1997. From molecular structure to Alzheimer therapy. Jpn. J. Pharmacol. 74, 225-241.
24. Giovannini, M.G., Casamenti, F., Nistri, A., Paoli, F., Pepeu, G., 1991. Effect of thyrotropin-releasing hormone (TRH) on acetylcholine release from different brain areas investigated by microdialysis. Br. J. Pharmacol. 102, 363-368.
25. Hinz, V.C., Grewig, S., Schmidt, B.H., 1996a. Metrifonate and dichlorvos: effects of a single oral administration on cholinesterase activity in rat brain and blood. Neurochem. Res. 21, 339-345.
26. Hinz, V.C., Grewig, S., Schmidt, B.H., 1996b. Metrifonate induces cholinesterase inhibition exclusively via slow release of dichlorvos. Neurochem. Res. 21, 331-337.
27. Hodges, H., Ribeiro, A.M., Gray, J.A., Marchbanks, R.M., 1990. Low-dose tetrahydroaminoacridine (THA) improves cognitive function but does not affect brain acetylcholine in rats. Pharmacol. Biochem. Behav. 36, 291-298.
28. Holmstedt, B., Nordgren, I., Sandoz, M., Sundwall, A., 1978. Metrifonate: summary of toxicological and pharmacological information available. Arch. Toxicol. 41, 3-29.
29. Jaen, J.C., Davis, R.E., 1993. Cholinergic therapies for Alzheimer's disease: acetylcholinesterase inhibitors of current clinical interest. Curr. Opin. Invest. Drugs 2, 363-377.
30. Johnson, C.D., Russell, R.L., 1975. A rapid, simple radiometric assay for cholinesterase, suitable for multiple determinations. Anal. Biochem. 64, 229-238.
31. Kristofikova, Z., Benesova, O., Tejkalova, H., 1992. Changes of high-affinity choline uptake in the hippocampus of old rats after long-term administration of two nootropic drugs (tacrine and Ginko biloba extract). Dementia 3, 304-307.
32. Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J., 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193, 265-275.
33. Messamore, E., Warpman, U., Ogane, N., Giacobini, E., 1993. Cholinesterase inhibitor effects on extracellular acetylcholine in rat cortex. Neuropharmacology 32, 745-750.
34. Mori, F., Cuadra, G., Giacobini, E., 1995. Metrifonate effects on acetylcholine and biogenic amines in rat cortex. Neurochem. Res. 20, 1081-1088.
35. Nielsen, J.A., Mena, E.E., Williams, I.H., Nocerini, M.R., Liston, D., 1989. Correlation of brain levels of 9-amino-1,2,3,4-tetrahydroacridine (THA) with neurochemical and behavioral changes. Eur. J. Pharmacol. 173, 53-64.
36. Nightingale, S.L., 1997. From the food and drug administration. Jama 277, 10.
37. Nillson, O.G., Adem, A., Hardy, J., Winblad, B., Norberg, A., 1987. Do tetrahydroaminoacridine (THA) and physostigmine restore acetylcholine release in Alzheimer brain via nicotinic receptors?. J. Neural Transm. 70, 357-368.
38. Nordberg, A., Nilsson-Hakansson, L., Adem, A., Lay, Z., Winblad, B., 1989. Multiple actions of THA on cholinergic neurotransmission in Alzheimer brains. Prog. Clin. Biol. Res. 317, 1169-1178.
39. Nordgren, I., Holmstedt, B., 1988. Metrifonate: a review. In: Giacobini, E., Becker, R. (Eds.), Current Research in Alzheimer Therapy. Taylor and Francis, New York, pp. 281-288.
40. Paxinos, G., Watson, G. (Eds.), 1982. The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
41. Pepeu, G., Giovannelli, L., 1994. The central cholinergic system during aging. Prog. Brain Res. 100, 67-71.
42. Riekkinen, P.J., Riekkinen, M., Sirviö, J., 1992. Effects of tetrahydroaminoacridine on spatial navigation of nucleus basalis- and frontal cortex-lesioned rats. Pharmacol. Biochem. Behav. 41, 637-641.
43. Riekkinen, M., Schmidt, B.H., Riekkinen, P.J., 1997. Subchronic treatment increases the duration of the cognitive enhancement induced by metrifonate. Eur. J. Pharmacol. 338, 105-110.
44. Sarter, M., 1991. Taking stock of cognition enhancers. Trends in Pharmacological Sciences 12, 456-461.
45. Scali, C., Casamenti, F., Pazzagli, M., Bartolini, L., Pepeu, G., 1994. Nerve growth factor increases extracellular acetylcholine levels in the parietal cortex and hippocampus of aged rats and restores object recognition. Neurosci. Lett. 170, 117-120.
46. Scali, C., Giovannini, M.G., Bartolini, L., Prosperi, C., Hinz, V., Schmidt, B.H., Pepeu, G., 1997a. Effect of metrifonate on extracellular brain acetylcholine levels and object recognition in aged rats. Eur. J. Pharmacol. 325, 173-180.
47. Scali, C., Giovannini, M.G., Prosperi, C., Bartolini, L., Pepeu, G., 1997b. Tacrine administration enhances extracellular acetylcholine in vivo and restores the cognitive impairment in aged rats. Pharmacol. Res. 36, 463-469.
48. Schmidt, B.H., Hinz, V.C., van der Staay, F.J., 1997. The preclinical pharmacology of metrifonate, a long-acting and well tolerated cholinesterase inhibitor for Alzheimer therapy. In: Fisher, A., Yoshida, M., Hanin, I. (Eds.), Progress in Alzheimer and Parkinson's Disease. Plenum, New York.
49. Soininen, H.S., Unni, L., Shillcut, S., 1990. Effect of acute and chronic cholinesterase inhibition on biogenic amines in rat brain. Neurochem. Res. 15, 1185-1190.
50. Squire, L.R., Davis, H.P., 1981. The pharmacology of memory: a neurobiological perspective. Annual Review of Pharmacology and Toxicology 21, 326.
51. Svensson, A.L., Xiao, Z., Nordberg, A., 1996. Biphasic effect of tacrine on acetylcholine release in rat brain via M1 and M2 receptors. Brain Res. 726, 207-212.
52. Taylor, P., 1996. Anticholinesterase agents. In: Hardman, J.L., Limbird, L.E. (Eds.), Goodman and Gilman's The Pharmacological Basis of the Therapeutics, 9th edn. McGraw-Hill, New York, pp. 161-176.
53. van der Staay, F.J., Hinz, V.C., Schmidt, B.H., 1996. Effects of metrifonate, its transformation product dichlorvos, and other organophosphorous and reference cholinesterase inhibitors on Morris water escape behavior in young-adult rats. J. Pharmacol. Exp. Ther. 278, 697-708.
54. Wagstaff, A.J., McTavish, D., 1994. Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease. Drug Evaluation 4, 510-540.
55. Webster Jr., L.T., 1990. Chemotherapy of parasitic infections. In: Goodman Gilman, A., Rail, T.W., Nies, A.S., Taylor, P. (Eds.), Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th edn. Pergamon, New York, p. 964.
56. Weinstock, M., 1995. The pharmacotherapy of Alzheimer's disease based on the cholinergic hypothesis: an update. Neurodegeneration 4, 349-356.
57. Wu, C.W., Bertorelli, R., Sacconi, M., Pepeu, G., Console, S., 1988. Decrease of brain acetylcholine release in aging freely-moving rats detected by microdialysis. J. Neurobiol. 9, 357-361.
58. Xiao, W.B., Nordberg, A., Zhang, X., 1993. Effect of in vivo microdialysis of 1,2,3,4-tetrahydro-9-aminoacridine (THA) on the extracellular concentration of acetylcholine in the striatum of anaesthetised rats. J. Pharmacol. Exp. Ther. 265, 759-764.